Jan Nilsson
Direttore/Membro del Consiglio presso CanImGuide Therapeutics AB
Profilo
Jan Nilsson is currently a Non-Executive Director at CanImGuide Therapeutics AB, a Director at Panion Animal Health AB, a Director at Urbicum Ledningskonsult AB, a Director at CarryGenes Therapeutics AB, and a Director at Immodulate Pharma AB.
His former positions include being the Chief Executive Officer & Director at Promore Pharma AB from 2011 to 2013, the Chief Executive Officer & Director at CombiGene AB from 2016 to 2023, the Chief Executive Officer at Neurovive Pharmaceutical AB from 2013 to 2016, the Chief Operating Officer at Abliva AB in 2016, and the Chief Commercial Officer at Pergamum AB.
Mr. Nilsson holds an MBA from the University of Uppsala and a graduate degree from the University of Gothenburg.
Posizioni attive di Jan Nilsson
| Società | Posizione | Inizio |
|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Direttore/Membro del Consiglio | - |
| Urbicum Ledningskonsult AB | Direttore/Membro del Consiglio | - |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Direttore/Membro del Consiglio | 20/08/2019 |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Direttore/Membro del Consiglio | - |
| Immodulate Pharma AB | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jan Nilsson
| Società | Posizione | Fine |
|---|---|---|
| COMBIGENE AB | Amministratore Delegato | 01/09/2023 |
| Neurovive Pharmaceutical AB | Amministratore Delegato | 01/09/2016 |
| ABLIVA AB | Amministratore Delegato | 14/03/2016 |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Amministratore Delegato | 01/01/2013 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Jan Nilsson
| University of Uppsala | Masters Business Admin |
| University of Gothenburg | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ABLIVA AB | Health Technology |
| COMBIGENE AB | Health Technology |
| Aziende private | 8 |
|---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
Panion Animal Health AB
Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Process Industries |
| Urbicum Ledningskonsult AB | |
CarryGenes Therapeutics AB
CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Commercial Services |
| Immodulate Pharma AB | |
| Neurovive Pharmaceutical AB |
- Borsa valori
- Insiders
- Jan Nilsson